Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander,...
-
Upload
eugene-coup -
Category
Documents
-
view
213 -
download
0
Transcript of Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander,...
![Page 1: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/1.jpg)
Dysfunctional but viable myocardium
Ischemic heart disease assessed by MRI and SPECT
Martin Ugander, MD
Department of Clinical Sciences, Lund
Department of Clinical Physiology
Lund University
![Page 2: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/2.jpg)
Supervisor: Håkan Arheden, MD, PhD
Clinical Physiology, Lund
Co-supervisor: Peter Cain, MBBS, PhD
Wesley Heart Clinic, Brisbane, AU
Funding:• Swedish Research Council• Swedish Heart Lung Foundation• Faculty of Medicine at Lund University• Region of Scania
![Page 3: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/3.jpg)
Aim
• To further elucidate the pathophysiology of dysfunctional but viable myocardium in patients with ischemic heart disease.
![Page 4: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/4.jpg)
Outline of Studies
• Study I - Method for quantitative MRI & SPECT
• Study II - Wall thickening vs. Infarct transmurality
• Study III - LVEF vs. Infarct size
• Study IV - Time course of perfusion & function
after revascularization
![Page 5: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/5.jpg)
Study I
Quantitative polar representation of left ventricular myocardial perfusion, function and viability using SPECT and cardiac magnetic resonance: initial results
Cain PA, Ugander M, Palmer J, Carlsson M, Heiberg E, Arheden H.
Clin Physiol Funct Imag 2005 (25) 215-222
![Page 6: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/6.jpg)
Background
• Clinical management of CAD involves complex assessment of the extent and severity of changes in function, perfusion and viability.
• No adequate research tools for quantitative assessment exist.
![Page 7: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/7.jpg)
Aims
• To explore the feasibility of integrative quantitative representation of LV perfusion, function and viability in polar plots.
• To determine agreement between visual scoring and quantitative measures.
![Page 8: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/8.jpg)
Methods
• 10 patients scheduled for CABG– rest/stress SPECT– Cine and delayed enhancment CMR
• Quantification with in-house software
• Comparison with visual scoring using Kendall’s coefficient of concordance (W)
![Page 9: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/9.jpg)
Methods
![Page 10: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/10.jpg)
![Page 11: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/11.jpg)
Results
![Page 12: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/12.jpg)
Results
Kendall’s W: 1.0 (p<0.001) 0.85 (p<0.001)
![Page 13: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/13.jpg)
Conclusions
• Side-by-side quantitative polar representation of LV perfusion, function and viability is feasible and may aid in the complex assessment of these parameters.
• The agreement between quantitative measurement and visual scoring was very good.
![Page 14: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/14.jpg)
Study II
Infarct transmurality and adjacent segmental function as determinants of wall thickening in revascularized chronic ischemic heart disease
Ugander M, Cain PA, Perron A, Hedström E, Arheden H.
Clin Physiol Funct Imag 2005 (25) 209-214
![Page 15: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/15.jpg)
Background
• Regional LV function in patients with IHD may be influenced by many factors.
![Page 16: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/16.jpg)
Aims
• To explore how regional wall thickening in patients with chronic IHD is affected by both infarct transmurality and the function of adjacent segments.
• To compare with results from healthy subjects.
![Page 17: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/17.jpg)
Methods
• 20 patients– 6 months after revascularization– Cine CMR– Delayed enhancement CMR
• 20 matched controls– Cine CMR
![Page 18: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/18.jpg)
![Page 19: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/19.jpg)
![Page 20: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/20.jpg)
![Page 21: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/21.jpg)
![Page 22: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/22.jpg)
Multivariate analysis of parameters contributing to
wall thickening t p
Infarct transmurality -4.5 <0.001
Number dysf. adjacent seg. -22.9 <0.001
![Page 23: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/23.jpg)
Conclusion
• The number of dysfunctional adjacent segments is a greater determinant than infarct transmurality on regional wall thickening.
• Infarction is difficult to assess by resting function alone.
• DE CMR is an important tool in this setting.
![Page 24: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/24.jpg)
Study III
A maximum predicted left ventricular ejection fraction in relation to infarct size in patients with ischemic heart disease
Ugander M, Ekmehag B, Arheden H.
Submitted
![Page 25: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/25.jpg)
Background
• An understanding of the relationship between LVEF and infarct size is important when assessing the potential benefit of revascularization in patients with IHD.
![Page 26: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/26.jpg)
Aims
• To explore the relationship between LVEF and IS.
• To determine a maximum predicted LVEF for a given IS.
![Page 27: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/27.jpg)
Methods
• 297 patients clinically referred for viability assessment by CMR
• LVEF
• Infarct size (% LVM)
![Page 28: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/28.jpg)
Methods
Infarct size (%LVM)
LVE
F (
%)
A
θ BC
![Page 29: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/29.jpg)
Patient characteristics (IHD)
![Page 30: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/30.jpg)
Distribution of infarctions
![Page 31: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/31.jpg)
Distribution of number of coronary artery vessel
territories
![Page 32: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/32.jpg)
Results
![Page 33: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/33.jpg)
Cine Contrast
LVEF=29% IS=36%
2ch
4ch
![Page 34: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/34.jpg)
Cine Contrast
LVEF=25% IS=6%
2ch
4ch
![Page 35: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/35.jpg)
Conclusions
• LVEF cannot be used to estimate IS.
• IS cannot be used to estimate LVEF.
• LVEF can be used to estimate a maximum predicted IS.
• IS can be used to estimate a maximum predicted LVEF.
![Page 36: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/36.jpg)
Study IV
Influence of the presence of chronic non-transmural myocardial infarction on the time course of perfusion and functional recovery after revascularization.
Ugander M, Cain PA, Johnsson P, Palmer J, Arheden H.
Manuscript
![Page 37: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/37.jpg)
Background
• The time course of recovery of LV function and perfusion after revascularization is not fully understood.
![Page 38: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/38.jpg)
Aims
• To study the effect of presence of infarction on the time course of recovery of perfusion and function after elective revascularization.
![Page 39: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/39.jpg)
Methods
• 15 patients (inclusion ongoing)– first time elective CABG (n=13) or PCI (n=2)
• Imaging– rest/stress SPECT– cine and delayed enhancement CMR– Before revasc., 1 & 6 months after revasc.
![Page 40: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/40.jpg)
Patient characteristics
• 14 men, 1 woman
• mean age 68 years (range 52-84)
• 3VD n=6
• 2VD n=6
• 1VD n=3
• LVEF = 49 10%
![Page 41: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/41.jpg)
Distribution of infarct transmuralities
![Page 42: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/42.jpg)
![Page 43: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/43.jpg)
Conclusions
• Dysfunctional segments without infarction improved both perfusion and function at 1 month.
• Segments with infarction showed improved perfusion at 1 month and improved function at 6 months.
• This may reflect more severe ischemic burden in segments with infarction.
![Page 44: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/44.jpg)
Summary
• Study I - Method for quantitative MRI & SPECT
• Study II - Wall thickening vs Infarct transmurality
• Study III - LVEF vs Infarct size
• Study IV - Time course of perfusion & function
after CABG
![Page 45: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/45.jpg)
Conclusion
• It is important to perform quantitative assessment of function,perfusion and viability in combination when studying the pathophysiology of dysfunctional but viable myocardium in IHD.
![Page 46: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/46.jpg)
www.med.lu.se/cmr
Martin Ugander, MD, PhD-student
Ann-Helen Arvidsson, tech
Erik Hedström, PhD
Marcus Carlsson, MD, PhD-student
Christel Carlander, tech
Håkan Arheden, MD PhD
Karin Markenroth, PhD
Bo Hedén, MD PhDHenrik Engblom, MD, PhD-student
Einar Heiberg ,PhD
Henrik Mosén, MD, PhD
Erik Bergvall, MSc, PhD-student
![Page 47: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/47.jpg)
![Page 48: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/48.jpg)
The ischemic cascade
![Page 49: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/49.jpg)
![Page 50: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/50.jpg)
![Page 51: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/51.jpg)
![Page 52: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/52.jpg)
Mahrholdt et al2005 Eur Heart J
![Page 53: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/53.jpg)
![Page 54: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/54.jpg)
![Page 55: Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.](https://reader035.fdocuments.us/reader035/viewer/2022081603/56649cb45503460f94977c4a/html5/thumbnails/55.jpg)